BRENTFORD, England, Aug. 17,
2021 /PRNewswire/ -- GSK NEXT, the disruptive
innovation arm of the science-led global consumer healthcare
company GSK, has set out to discover, incubate, and scale new
businesses across the changing face of everyday health and
wellbeing. As part of that effort, GSK NEXT has launched the
Re/Wire Health Studio, an initiative that invites emerging
consumer health and technology companies to partner with GSK's
consumer division to provide better access to everyday health care,
create seamless everyday health experiences, and improve health
outcomes for consumers.
The Re/Wire Health Studio is built to collaborate with
startups focused on next generation diagnostic solutions that
address evolving consumer needs. Each focus area is aligned with
core ideas surrounding everyday health issues that are prevalent
amongst consumers specifically related to:
- Oral Health
- Women's Health & Wellness
- Mental Resilience
"If there's one thing the pandemic has taught us, it's that
amazing solutions happen with the right collaborative spark. We're
seeing huge disruption and partnership opportunities in the
consumer health space and we're excited about fusing the trusted
science and scale of GSK Consumer Healthcare with brilliant new
thinkers and makers across everyday health," said GSK Vice
President and Head of NEXT, Nick
Tate.
The Studio invites applications from innovative growth- and
early-stage companies with disruptive technologies that will shape
the future of consumer health. GSK welcomes startups from around
the world to apply, but must be capable and prepared to launch in
the U.S. with a minimum viable product or service in development or
in-market. The Studio will identify strategic opportunities for
startups to partner with GSK and provide the selected Studio
companies with the market opportunities, guidance, and partnerships
to build momentum towards scaling globally.
R/GA Ventures will act as an operational partner in the Studio,
contributing to the overall innovation strategy, startup selection,
and nine-week Studio execution. The six startups selected will have
access to R/GA's creative capital services with award-winning
strategists, technologists, designers, and consultants to help them
develop their businesses and prepare them for future
milestones.
Startup applications to participate in the Studio are now open
through September 20, 2021. The final
cohort will be selected by October 11,
2021. The Studio will kick off in November 2021 and run through January 2022.
For more information about the Re/Wire Health Studio, please
visit: rewirehealthstudio.com and follow @GSK and @rgaventures
on Twitter.
About GSK NEXT
GSK NEXT is the strategic commercial
growth engine for GSK Consumer Healthcare, focused on the creation
and scaling of net-new product, service and platform businesses
across everyday health.
About R/GA Ventures
R/GA Ventures helps industry
leaders embrace disruption, connecting them with emerging startups,
technologies and consumer behaviors to drive their businesses
forward. Since 2013, R/GA Ventures has run 15 programs to date and
has a portfolio of more than 90 companies across a variety of
verticals. R/GA Ventures and R/GA are part of the Interpublic Group
of Companies (NYSE: IPG), one of the world's largest advertising
and marketing services organizations. Learn more at
ventures.rga.com and by following @rgaventures.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/gsk-next-launches-the-rewire-health-studio-with-rga-ventures-to-explore-and-scale-new-everyday-health-solutions-301357165.html
SOURCE R/GA Ventures